Senior Scientific and Executive Team Members to be Featured Speakers
PITTSBURGH, June 16 /PRNewswire/ -- invivodata inc., the industry leader in electronic patient reported outcomes (ePRO) solutions and services for global clinical research, today announced that members of its senior scientific and executive management team will be featured speakers at the Drug Information Association (DIA) 45th Annual Meeting in San Diego, Calif., June 21-25, 2009.
This is the eighth consecutive year that invivodata has had a significant presence at this global industry event. Representing invivodata at this year's meeting are:
In Booth No. 1706, invivodata will showcase its global ePRO solutions, including DiaryPRO(R) 210, its proven field-based electronic diary delivered on the Windows Mobile operating system and the Hewlett-Packard iPAQ(R) 210 device. invivodata will also be demonstrating its large-screen, site-based ePRO solution - the SitePRO(R) Tablet, which offers significant efficiencies by eliminating the time-intensive management of paper-based assessments typically completed by trial subjects during site visits.
Additionally, regulatory and scientific experts from invivodata and its consulting division, PRO Consulting(TM) will be available to answer questions about PRO strategy development and selecting the right PRO measures and methods to assess treatment effect in support of regulatory submissions.
For more information on invivodata's DIA activities, please visit www.invivodata.com.
About invivodata inc.
invivodata combines behavioral science, information technology, and clinical research expertise to capture high quality clinical trial data directly from patients. invivodata's electronic Patient Reported Outcomes (ePRO) solutions, which are based on over 20 years of research, deliver reliable patient self-reported data by driving patient compliance with the protocol and eliminating recall biases that plague paper-based self-report data. invivodata's solutions include comprehensive trial-support services that facilitate the collection of ePRO data, web-based access to study data and operational reports that give researchers and sponsors visibility into study progress, and scientific and regulatory consulting on the use of PRO data in a regulated environment. invivodata's solution has been used in more than 275 clinical programs and is the industry-leading ePRO system in delivering primary efficacy data for FDA drug approvals. invivodata inc. is a privately held company with global headquarters in Pittsburgh, Pa., USA; its European headquarters are in London, England; and its technology development center is in Scotts Valley, Calif., USA. For more information visit www.invivodata.com.
CONTACT: Christine Tobin, Corporate Communications Specialist, invivodata
inc., +1-412-390-3000, ext. 3502, ctobin@invivodata.com
Web site: http://www.invivodata.com/
